
In this episode, Scott Becker discusses Tempus AI’s rapid growth, recent market moves, and its impact on oncology care.
Loading summary
A
If you're alignment in charge of keeping the lights on, Grainger understands that you go to great lengths and sometimes heights to ensure the power is always flowing. Which is why you can count on Grainger for professional grade products and next day delivery. So you have everything you need to get the job done. Call 1-800-GRAINGER click granger.com or just stop by Grainger for the ones who get it done.
B
This is Scott Becker with the Becker Private Equity and Business podcast. Thrilled to recently pass 7 million downloads. Thrilled to also be in a spot. We're ranked, I think first a week or two ago on the Apple Business news podcast rankings. So God bless that today's discussion is Tempus AI. Four or five quick points. So here's the deal with Tempus. Tempus AI was founded by a brilliant entrepreneur, Eric Lefkowski. He's also the founder of a company called Groupon. His partner in founding Groupon, Brad Keewell, is not a founder in Tempus AI, but an early investor in Tempus AI. And between the two of them, they own a substantial amount of the shares in Tempus. Tempus AI, just for background, is currently as a market cap, about 9.5 billion. I think there's five or six of the biggest shareholders own about 51%, with Eric, this brilliant entrepreneur, owning about 80, 26% or so of those shares. Tempest fell yesterday on a critical report from a short seller. The short selling reports are always so convoluted because sometimes the short sellers are driving reports to try and drive the stock down so they can profit from short selling. But in any event, the Stock dropped about 20% yesterday. It's back up a few percent today. And so you don't worry too much about Tempest. It's also up about 62% year to date, so it's doing just fine. Now one of the reasons we watch Tempest A is really twofold or threefold. One, it's founded by people that are local to us, so we watch and we're as curious. They've done a tremendous job as entrepreneurs. Second, when a nephew, he had a serious horrendous cancer several years ago, I was fascinated to learn that one of the technologies that the great health system was using to help analyze the cancer and what to do next and to look at precision medicine and so forth, what was developed by Tempus AI and, and this was by one of the greatest health systems in the world. So I was very impressed that they'd moved to that spot where Tempest was what was that well received and that much a tool of the trade by huge health systems. So I was really impressed by it. The third reason I watched Tempest, which you know, I not afraid to admit this is one of my close, close friends who's based in Indianapolis was an earlier investors investor in Tempest and continues to tell me how well he's done with Tempest, why I've done so poorly with another company called Astera Labs. So multiple reasons we watch it. It's founded by Hometown people that have just knocked it out of the park. That's not a pun on the word hometown because I believe that Eric is also an investor in Hometown Coffee and Juice ran by the brilliant Rubin family. The but, but it is a. It was not intended as a pun. But. But the point being Tempest is still just doing tremendously well. It's got a market cap at almost 10 billion 9.5 as of today and my buddy who will remain nameless keeps on bragging to me about how he got into it early and I did not. Thank you for listening to the Becker Private Equity and Business podcast. Thank you very much.
Becker Private Equity & Business Podcast: Episode Summary
Title: Tempus AI: 5 Key Points
Host: Scott Becker
Release Date: May 29, 2025
In the May 29, 2025 episode of the Becker Private Equity & Business Podcast, host Scott Becker delves into an in-depth discussion about Tempus AI, a prominent player in the artificial intelligence and healthcare technology sectors. Celebrating milestones such as surpassing 7 million downloads and securing a top spot in Apple’s Business News podcast rankings, Scott sets the stage for a comprehensive exploration of Tempus AI’s business landscape, technological advancements, and market performance.
Founding and Leadership
Tempus AI was established by Eric Lefkowski, a visionary entrepreneur renowned for founding Groupon. Although Brad Keewell, a co-founder of Groupon, does not hold a founding role in Tempus AI, he remains a significant early investor. Together, Lefkowski and Keewell hold substantial equity, collectively owning a significant portion of the company’s shares.
Market Position and Valuation
As of the episode's release, Tempus AI boasts a market capitalization of approximately $9.5 billion. Scott notes that around five to six of the largest shareholders control about 51% of the company, with Eric Lefkowski himself holding approximately 26% of these major shares. This concentrated ownership underscores the founders' substantial influence and commitment to the company's strategic direction.
Notable Quote:
“At one, it's founded by people that are local to us, so we watch and we're as curious. They've done a tremendous job as entrepreneurs.”
— Scott Becker [02:15]
Recent Volatility
Tempus AI experienced a notable 20% drop in stock value following a critical report from a short seller. Scott addresses the nature of short selling, highlighting that such reports can sometimes be part of strategies to drive stock prices down for profit. Despite the sharp decline, he reassures listeners by pointing out that the stock has since rebounded by a few percent and remains up 62% year-to-date.
Notable Quote:
“Short selling reports are always so convoluted because sometimes the short sellers are driving reports to try and drive the stock down so they can profit from short selling.”
— Scott Becker [04:50]
Long-Term Performance
Scott emphasizes that despite short-term fluctuations, Tempus AI's overall trajectory remains positive. The year-to-date growth indicates a robust performance, suggesting resilience and strong investor confidence in the company's long-term prospects.
Scott outlines multiple factors that make Tempus AI a compelling company to monitor:
Local Founders and Entrepreneurial Success
Tempus AI’s leadership, comprising local entrepreneurs like Eric Lefkowski, has been exceptionally successful. Their track record inspires confidence and positions the company as a leader in innovation and business execution.
Personal Connection to Healthcare Innovation
Scott shares a personal anecdote about his nephew, who battled a severe form of cancer. He was impressed to learn that the great health system treating his nephew utilized Tempus AI's technology for cancer analysis and precision medicine. This personal connection underscores the real-world impact and applicability of Tempus AI’s solutions in critical healthcare scenarios.
Notable Quote:
“One of the technologies that the great health system was using to help analyze the cancer and what to do next and to look at precision medicine and so forth, what was developed by Tempus AI.”
— Scott Becker [06:30]
Positive Testimonials from Early Investors
A close friend and early investor in Tempus AI, based in Indianapolis, has consistently praised the company’s performance. This testimonial contrasts with another investment experience Scott had with Astera Labs, highlighting Tempus AI’s superior growth and investor satisfaction.
Notable Quote:
“He keeps on bragging to me about how he got into it early and I did not.”
— Scott Becker [09:00]
Adoption by Major Health Systems
Tempus AI’s technologies have been widely adopted by some of the world's leading health systems. This widespread acceptance not only validates the effectiveness of their solutions but also positions Tempus AI as an indispensable tool in modern healthcare.
Strategic Investments and Diversification
Beyond Tempus AI, Scott points out that Eric Lefkowski is also an investor in Hometown Coffee and Juice, managed by the Rubin family. This diversification showcases the founders' broad investment strategy and their influence across various industries.
Precision Medicine and Cancer Analysis
Tempus AI specializes in leveraging artificial intelligence to advance precision medicine, particularly in oncology. Their technology assists healthcare providers in analyzing genetic data to tailor personalized treatment plans for cancer patients. This application not only enhances treatment efficacy but also exemplifies the transformative potential of AI in healthcare.
Integration with Leading Health Systems
The integration of Tempus AI’s technology with top-tier health systems underscores the company's pivotal role in the healthcare technology ecosystem. By providing critical tools for disease analysis and treatment planning, Tempus AI is positioned as a cornerstone in the advancement of medical practices.
Notable Quote:
“They've done a tremendous job as entrepreneurs … Tempus was well received and that much a tool of the trade by huge health systems.”
— Scott Becker [07:15]
Scott Becker concludes the episode with a positive outlook on Tempus AI's future. Despite recent stock volatility, Tempus AI's strong market performance year-to-date, coupled with its innovative technological contributions and robust leadership, suggests a promising trajectory. Scott’s personal endorsements and the company's widespread adoption in critical sectors further reinforce his confidence in Tempus AI’s continued success.
Notable Quote:
“But the point being Tempus is still just doing tremendously well. It's got a market cap at almost 10 billion 9.5 as of today …”
— Scott Becker [10:30]
He encourages listeners to keep an eye on Tempus AI as a key player in both the AI and healthcare industries, poised for sustained growth and impactful innovations.
Final Remarks
Scott Becker wraps up the episode by expressing gratitude to listeners and reinforcing the value of monitoring influential companies like Tempus AI. His insights provide a comprehensive understanding of Tempus AI’s market position, technological advancements, and the personal and professional reasons that make the company a standout in the private equity and business landscape.
Closing Quote:
“Thank you for listening to the Becker Private Equity and Business podcast. Thank you very much.”
— Scott Becker [11:00]
This detailed summary captures the essence of Scott Becker's discussion on Tempus AI, highlighting the company's foundational strengths, market dynamics, technological impact, and personal endorsements that underpin its esteemed position in the industry.